3 beta-hydroxysteroid dehydrogenase type II

Known as: 3 beta-hydroxysteroid dehydrogenase type 2, HSD3B2 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1995-2018
0246819952018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
CONTEXT Therapeutic management of primary aldosteronism requires accurate differentiation between aldosterone-producing adenoma… (More)
Is this relevant?
2012
2012
Metformin is treatment of choice for the metabolic consequences seen in polycystic ovary syndrome for its insulin-sensitizing and… (More)
Is this relevant?
2010
2010
Orphan nuclear receptor NR4A1, a member of the nuclear receptor superfamily, is widely expressed in different cell types and… (More)
  • figure 1
  • figure 3
  • figure 4
Is this relevant?
2007
2007
Thiazolidinediones (TZDs) such as pioglitazone and rosiglitazone are widely used as insulin sensitizers in the treatment of type… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2007
2007
BACKGROUND 3beta-Hydroxysteroid dehydrogenase type II deficiency, a rare form of congenital adrenal hyperplasia, is characterized… (More)
Is this relevant?
2005
2005
In order to establish whether there are differences in DNA-binding proteins between zona fasciculata (ZF) and zona reticularis… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2004
2004
3beta-Hydroxysteroid dehydrogenase type 2 (HSD3B2) is a steroid-metabolizing enzyme that is essential for adrenal production of… (More)
Is this relevant?
2003
2003
After ovulation, ovarian 3beta-hydroxysteroid dehydrogenase type II (HSD3B2) expression increases to enhance the shift of… (More)
Is this relevant?
1995
1995
The enzyme 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase (3 beta-HSD) catalyses an essential step in the… (More)
Is this relevant?